SCHEMBL5133435

SCHEMBL5133435

O=C1COc2ccc(Br)cc2N1CCN1CC[CH]CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.55
DRD4 P21917 1/20 0.47
KMO O15229 1/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
EGFR P00533 3/20 0.43
PIM1 P11309 1/20 0.42
TSHR P16473 2/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
PKM P14618 1/20 0.42
NPR1 P16066 1/20 0.42
BLM P54132 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PIK3CG P48736 1/20 0.41
HTT P42858 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA1B P35368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5133211 0.86 KCNH2 (0.55) KCNH2DRD4KMOCYP3A4CYP2C9
SCHEMBL706643 0.84 KCNH2 (0.57) KCNH2DRD4KMOCYP3A4CYP2C9
SCHEMBL5134628 0.83 DRD4 (0.66) KCNH2DRD4TSHRHTR1AADRA1B
SCHEMBL921527 0.79 KCNH2 (0.59) KCNH2CYP3A4CYP2C9CYP2C19ADRA1B
SCHEMBL709161 0.78 KCNH2 (0.51) KCNH2KMOCYP3A4CYP2C9CYP2C19
SCHEMBL16184461 0.76 HTT (0.51) KCNH2KMOCYP3A4CYP2C19TSHR
SCHEMBL29093154 0.76 KCNH2 (0.48) KCNH2DRD4KMOCYP3A4CYP2C9
SCHEMBL21641747 0.74 KMO (0.45) KCNH2KMOCYP3A4TSHRTP53
SCHEMBL1047741 0.74 REN (0.57) KMOTSHRTP53HTT
SCHEMBL16897903 0.74 CYP3A4 (0.61) DRD4CYP3A4CYP2C9CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed